平特五不中

平特五不中

D2R Community News

D2R announces new round of funding, investing $1.5 million to advance research in RNA therapeutics and to support 平特五不中 Centres and Institutes
Published: 19 Dec 2024
Research | A new trial hopes to use mRNA to halt the devastating progression of Creutzfeldt-Jakob Disease
Published: 9 Dec 2024
Event | Seminar, The power of first impressions: Using viral imprinting for broadly reactive vaccine development | Dec 11, 2024
Published: 29 Nov 2024
CQDM partners with D2R to enhance collaborations among researchers and industry in RNA research
Published: 28 Nov 2024
Event | Workshop in Precision Health and Medicine | January 9, 2025
Published: 25 Nov 2024
Event | MI4 6th Annual Scientific Symposium | December 4, 2024
Published: 15 Nov 2024
Event | Practical examples of research in indigenous context | November 20, 2024
Published: 15 Nov 2024
Event | Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder | November 14, 2024
Published: 12 Nov 2024
Philippe Gros appointed Chief Scientific Officer of D2R
Published: 31 Oct 2024
D2R welcomes RNA and genomic researchers to Universit茅 de Sherbrooke
Published: 31 Oct 2024

Back to top